Vermont Business Magazine Attorney General Thomas JDonovan, Jryesterday joined 39 other state attorneys general in a lawsuit against six generic drug makers. The six companies allegedly entered into illegal conspiracies to reduce competition for generic drugs and raise the prices of those drugs. The states contend that the defendant drug companies coordinated with their competitors at events like industry trade shows, as well as by email, phone and text messages, and that they violated state and federal antitrust laws and state consumer protection laws.
“Generic drugs are an important means of making health care more affordable,” said Attorney General Donovan. “This lawsuit is an important step in addressing the harm caused by generic drug manufacturers who seek to maximize their profits at the expense of consumers. Consumers have the right to expect that their health care costs are unaffected by illegal conduct.”
The lawsuit against drug makers Heritage Pharmaceuticals, Inc., Aurobinda Pharma USA, Inc., Citron Pharma, LLC, Mayne Pharma (USA), Inc., Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc. is pending in federal court in Connecticut. The lawsuit is filed under seal and portions of the court filings are redacted. A copy of the Amended Complaint filed on March 1, 2017 ishere.
Source: Vermont AG. March 2, 2017